Tetraphase Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

20:00 EDT 5 Aug 2015 | Globe Newswire

WATERTOWN, Mass., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that company management will present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 12th at 3:05 p.m. Eastern Time at Le Parker Meridien Hotel in New York City.

A live audio webcast of the Wedbush presentation will be available on the company's website at An archived presentation will be available for 90 days.

About Tetraphase Pharmaceuticals, Inc.

Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening MDR bacterial infections, including those caused by many of the MDR Gram-negative bacteria highlighted as urgent public health threats by the CDC. Tetraphase has created more than 3,000 novel tetracycline analogs using its proprietary technology platform. Tetraphase's pipeline includes eravacycline, a broad-spectrum intravenous and oral antibiotic that is being evaluated in phase 3 clinical trials, and two preclinical antibiotic candidates, TP-271 and TP-6076. Please visit for more company information.

CONTACT: Investor Contacts:
         Tetraphase Pharmaceuticals
         Teri Dahlman
         Argot Partners
         Susan Kim
         Media Contact:
         Sam Brown Inc.
         Mike Beyer

Tetraphase Logo


More From BioPortfolio on "Tetraphase Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...